April News available from Cresset

Cresset's latest newsletter looks at GSK’s discovery of a series of potent and selective inhibitors of PKR-like endoplasmic reticulum kinase (PERK); describes a new version of Cresset’s KNIME nodes; and gives further details on its plan to dramatically change the landscape for field-based virtual screening.



Read more

Looking for something specific?